Jean-louis L. Georges

Le Chesnay, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial.

Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial.

Journal: JAMA cardiology

Published: February 25, 2026

Intensive patient education by specialized nurses taking care of patients with heart failure: Results of the EDUSTRA-HF trial on the primary endpoint.

Intensive patient education by specialized nurses taking care of patients with heart failure: Results of the EDUSTRA-HF trial on the primary endpoint.

Journal: Archives of cardiovascular diseases

Published: December 08, 2025

End for the special CNCH issue of the « Annales de cardiologie et angéiologie ».

End for the special CNCH issue of the « Annales de cardiologie et angéiologie ».

Journal: Annales de cardiologie et d'angeiologie

Published: October 25, 2025

Definition and Prediction of Periprocedural Myocardial Infarction in Elective Percutaneous Coronary Intervention: The ALPHEUS-MI Study.

Definition and Prediction of Periprocedural Myocardial Infarction in Elective Percutaneous Coronary Intervention: The ALPHEUS-MI Study.

Journal: The Canadian journal of cardiology

Published: August 26, 2025

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial.

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial.

Journal: European heart journal

Published: July 21, 2025

When the Stent Gets Gift-Wrapped.

When the Stent Gets Gift-Wrapped.

Journal: JACC. Cardiovascular interventions

Published: May 16, 2025

Twice-a-day administration of aspirin in patients with diabetes mellitus or aspirin resistance after acute coronary syndrome: Rationale and design of the randomized ANDAMAN trial.

Twice-a-day administration of aspirin in patients with diabetes mellitus or aspirin resistance after acute coronary syndrome: Rationale and design of the randomized ANDAMAN trial.

Journal: American heart journal

Published: March 20, 2025

Outpatient percutaneous coronary interventions: Yes we can!

Outpatient percutaneous coronary interventions: Yes we can!

Journal: Annales de cardiologie et d'angeiologie

Published: October 20, 2024

Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trial.

Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trial.

Journal: European heart journal

Published: August 21, 2024

Acute myocarditis secondary to Graves' disease: A case report

Acute myocarditis secondary to Graves' disease: A case report

Journal: Annales de cardiologie et d'angeiologie

Published: August 15, 2024

Preliminary evaluation of the interest of a therapeutic optimization cell on the titration of treatments for heart failure with reduced left ventricular ejection fraction and the quality of life of patients

Preliminary evaluation of the interest of a therapeutic optimization cell on the titration of treatments for heart failure with reduced left ventricular ejection fraction and the quality of life of patients

Journal: Annales de cardiologie et d'angeiologie

Published: July 28, 2024

Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in women.

Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in women.

Journal: European journal of preventive cardiology

Published: March 27, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026